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SFN-rich broccoli sprouts in subjects at a high-risk of developing 
psychosis may prevent the onset of psychosis at adulthood.
PM366
Three-dimensional analysis of morphological 
changes in dendritic spines and mitochondria in 
dentate gyrus granule cells in Schnurri-2 knockout 
mice, an animal model for schizophrenia
Akito Nakao,
Fujita Health University, Japan
Abstract
Accumulating evidence suggests that morphological changes of 
subcellular-scale structures such as dendritic spine and mito-
chondria may be involved in the pathogenesis/pathophysiology 
of schizophrenia. Previously, we have proposed mice lacking 
Schnurri-2 (Shn2), an MHC enhancer binding protein, as a schizo-
phrenia model with mild chronic inflammation. In the mutants, 
there are decreases in the expression level of PSD95, synaptic 
marker, and increases in C1q family genes (C1qa, C1qc and C1ql2), 
which are considered to mediate synapse elimination during the 
postnatal development. In the present study, we analyzed three-
dimensional morphological changes in dendritic spines and mito-
chondria in dentate gyrus granule cells in Shn2 KO mice by serial 
block-face scanning electron microscopy. The mutants showed 
about 13% increase in spine length, and about 25% increase in 
spine neck length. There were no significant differences between 
Shn2 KO and wild-type mice in their spine density, volume of 
spine, spine head length, or spine head diameter. The mutants 
exhibited reduced complexity in mitochondrial morphology, sug-
gesting that a balance between mitochondrial fusion and fission 
is compromised in Shn2 KO mice. These morphological changes 
in spines and mitochondria may be associated with functional 
impairments of those subcellular-scale structures, and represent 
potential endophenotype of schizophrenia.
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Abstract
Background: Maternal immune activation (MIA) during preg-
nancy is a risk factor for schizophrenia and may be linked to 
cognitive deficits of the disorder [1,  2]. Current antipsychotics 
show minimal improvement of cognitive deficits [3] and have 
adverse side-effects [4]. Cannabidiol (CBD), a constituent of can-
nabis, possesses anti-inflammatory, antipsychotic and neuro-
protective properties [5]; however, whether CBD can improve 
cognition in schizophrenia is unknown. The aim of this study 
was to examine effects of CBD on cognition in a MIA model of 
schizophrenia.
Methods: Pregnant dams were administered either poly IC (POLY; 
4mg/kg) or saline (CONT). From postnatal day 56, offspring were 
administered either vehicle (CONT+VEH, POLY+VEH) or CBD 
(10 mg/kg; CONT+CBD, POLY+CBD) twice daily for 3 weeks (n=12 
males, 12 females/group). Novel object recognition (NOR) and 
T-maze tests were performed to assess recognition and working 
memory.
Results: In the NOR test, POLY+VEH males spent significantly 
less time exploring the novel object compared to CONT+VEH 
counterparts (p<0.01), and in the T-maze test, POLY+VEH 
males exhibited a lower number of correct entries (p<0.01 vs. 
CONT+VEH). Performance of POLY+CBD males was significantly 
better than POLY+VEH in both tests (p<0.05) and did not differ 
from CONT+VEH (p>0.05). No differences were observed between 
CONT+VEH and CONT+CBD males (p>0.05). There was no effect 
of poly IC or CBD treatment on female offspring performance in 
either test (p>0.05).
Conclusions: Interestingly, CBD treatment restored working 
and recognition memory impairments in the poly IC model of 
schizophrenia, but had no effect in control rats. These effects 
were observed in male offspring, whereas females showed no 
cognitive impairment. The mechanisms underlying the appar-
ent protection in females and sensitivity in males warrant fur-
ther investigation. This is the first study to examine chronic 
CBD treatment effects in a MIA model, and suggests that CBD 
may have sex-specific therapeutic potential for schizophrenia-
related cognitive impairments.
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Abstract
Objective: Impaired glucose and energy metabolism may 
play a role in the pathobiology of schizophrenia. Abnormal 
brain energy metabolism has been found in animal models of 
